Cited by 149Dementia and Cognitive Impairment ResearchAlzheimer's disease research and treatmentsNeuroinflammation and Neurodegeneration Mechanisms

The DOI matches its Crossref record; 55 of the 55 references it cites were found in a registry or an index.

Neurodegeneration in Normal Brain Aging and Disease

Thal, Dietmar Rudolf, Del Tredici, Kelly, Braak, Heiko·2004·Science of Aging Knowledge Environment

Abstract

Normal "healthy" aging is defined as aging without disease. Many aged people do not exhibit symptoms of disease and lead normal lives, but nonetheless display pathological changes that are characteristic of Alzheimer's disease (AD), Parkinson's disease (PD), dementia with Lewy bodies (DLB), and/or cerebrovascular disease (CVD). These changes are restricted to distinct brain regions and might represent preclinical stages of these disorders. This Perspective discusses arguments in favor of and against the hypothesis that pathological changes related to AD, PD, DLB, and CVD in the brains of nondemented elderly people represent early stages of these diseases rather than healthy aging. We conclude that early pathological disease-related changes do indeed constitute the beginning of AD, PD, DLB, and CVD rather than normal concomitants of aging, even in the absence of any clinical symptoms. Aging is, therefore, a major risk factor for these diseases but does not necessarily lead to age-related diseases.

Overview

Integrity signals

Registry

Crossref · 10.1126/sageke.2004.23.pe26

Cites

55 of 55 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 55 references

Research works printed but not linked: 10

  1. K. Iqbal, I. Grundke-Iqbal, T. Zaidi, P. A. Merz, G. Y. Wen, S. S. Shaikh, H. M. Wisniewski, I. Alafuzoff, B. Winblad, Defective brain microtubule assembly in Alzheimer's disease. Lancet 2, 421-426 (1986).
  2. C. L. Masters K. Beyreuther in Neurodegeneration: The Molecular Pathology of Dementia and Movement Disorders D. Dickson Ed. (ISN Neuropath Press Basel Switzerland 2003) pp. 69-73.
  3. K. A. Jellinger Y. Mizuno in Neurodegeneration: The Molecular Pathology of Dementia and Movement Disorders D. Dickson Ed. (ISN Neuropath Press Basel Switzerland 2003) pp. 159-187.
  4. J. S. Lowe N. Leigh in Greenfield's Neuropathology D. I. Graham P. L. Lantos Eds. (Arnold London 2002) vol. 2 pp. 325-430.
  5. K. A. Jellinger, J. Attems, alpha-synuclein pathology in Parkinson and Alzheimer diseases. Brain Pathol. 13 (suppl.) , S32 (2003).
  6. Y. Tsuboi, T. Iwatsubo, D. W. Dickson, Striatal alpha-synuclein (ASN) burden correlates with disease duration in Parkinson's disease, but not dementia with Lewy bodies. Brain Pathol. 13 (suppl.) , S32-S33 (2003).
  7. H. Kalimo M. Kaste M. Haltia in Greefield's Neuropathology 6th Edition D. I. Graham P. L. Lantos Eds. (Arnold London 1997) vol. 1 pp. 315-396.
  8. R. N. Kalaria, The cerebral amyloid angiopathies, microvascular degeneration and dementia. Brain Pathol. 13 (suppl.) , S83 (2003).
  9. H. V. Vinters in Stroke. Pathophysiology Diagnosis and Management H. J. M. Barnett J. P. Mohr B. M. Stein F. M. Yatsu Eds. (Churchill Livingstone New York 1992) pp. 821-858.
  10. D. R. Thal H. Braak Postmortale diagnosestellung bei morbus Alzheimer. Pathologe in press.

Cited by

Sorted by citations

Metadata

Authors
Thal, D. R., Del Tredici, K., & Braak, H.
Affiliations
  • Goethe University Frankfurt (DE)
  • Dietmar R. Thal is in the Department of Neuropathology at the University of Bonn Medical Center, Sigmund Freud Strasse 25, D-53105 Bonn, Germany. Kelly Del Tredici and Heiko Braak are at the Institute for Clinical Neuroanatomy at Johann Wolfgang Goethe University, D-60590 Frankfurt am Main, Germany.(D.R.T.)
Venue
Science of Aging Knowledge Environment
Published
2004-06-09
Volume
2004
Issue
23
Pages
pe26-pe26
ISSN
1539-6150 (ISSN-L)
OpenAlex
W2116204362
Cited by
149
References
55
Citations by year
2026: 4 · 2025: 4 · 2024: 5 · 2023: 5 · 2022: 8 · 2021: 6 · 2020: 3 · 2019: 5 · 2018: 4 · 2017: 5 · 2016: 5 · 2015: 10 · 2014: 4 · 2013: 7 · 2012: 9
FWCI
1.22
Type
journal article
Language
en
Open access
closed
Locations
  • Science of Aging Knowledge Environment (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
  • Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
  • Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
Keywords
neurodegeneration, healthy brain aging, preclinical disease, Alzheimer's disease, Parkinson's disease, dementia with Lewy bodies, cerebrovascular disease, aging as risk factor
MeSH terms
Aged, Aging, Alzheimer Disease, Brain, Cerebrovascular Disorders, Humans, Parkinson Disease, Neurodegenerative Diseases, Lewy Body Disease

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review